Search Results - "Busceti, M T"

Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non-small lung cancer cells by Pelaia, G., Gallelli, L., Renda, T., Fratto, D., Falcone, D., Caraglia, M., Busceti, M. T., Terracciano, R., Vatrella, A., Maselli, R., Savino, R.

“…Objective 3‐hydroxy‐3‐methylglutaryl‐coenzyme A (HMG‐CoA) reductase inhibitors (statins) can affect post‐translational processes, thus being responsible for…”
Get full text

Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma by Pelaia, G, Gallelli, L, Romeo, P, Renda, T, Busceti, M T, Proietto, A, Grembiale, R D, Marsico, S A, Maselli, R, Vatrella, A

“…Omalizumab is a humanized monoclonal anti-IgE antibody approved in 2005 by the European Medicine Agency (EMA) for the treatment of severe persistent allergic…”
Get full text

Effects of budesonide on P38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells by Gallelli, L, Pelaia, G, Fratto, D, Muto, V, Falcone, D, Vatrella, A, Curto, L S, Renda, T, Busceti, M T, Liberto, M C, Savino, R, Cazzola, M, Marsico, S A, Maselli, R

“…Non-typeable Haemophilus influenzae (NTHi) is one of the most frequently involved pathogens in bacterial exacerbations of chronic obstructive pulmonary disease…”
Get more information

Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy by Novelli, Federica, Latorre, Manuela, Vergura, Letizia, Caiaffa, Maria Filomena, Camiciottoli, Gianna, Guarnieri, Gabriella, Matucci, Andrea, Macchia, Luigi, Vianello, Andrea, Vultaggio, Alessandra, Celi, Alessandro, Cazzola, Mario, Paggiaro, Pierluigi

“…Abstract Few data are available on the proportion of asthmatics achieving a good asthma control (according GINA guidelines) and on the level of airway…”
Get full text

Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis by Pelaia, Corrado, Lombardo, Nicola, Busceti, Maria Teresa, Piazzetta, Giovanna, Crimi, Claudia, Calabrese, Cecilia, Vatrella, Alessandro, Pelaia, Girolamo

“…Having been approved for biological treatment of atopic dermatitis, dupilumab has also been recently licensed as add-on therapy for severe asthma and nasal…”
Get full text

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab by Pelaia, Corrado, Vatrella, Alessandro, Busceti, Maria Teresa, Gallelli, Luca, Terracciano, Rosa, Savino, Rocco, Pelaia, Girolamo

“…Mepolizumab is an anti-interleukin-5 (IL-5) humanized monoclonal antibody that has been recently approved as an add-on biological treatment for severe…”
Get full text

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD by Pelaia, Girolamo, Vatrella, Alessandro, Busceti, Maria Teresa, Gallelli, Luca, Calabrese, Cecilia, Terracciano, Rosa, Lombardo, Nicola, Maselli, Rosario

“…Bronchodilators are the most important drugs used for the treatment of chronic obstructive pulmonary disease (COPD). In particular, these therapeutic agents…”
Get full text

Role of biologics in severe eosinophilic asthma - focus on reslizumab by Pelaia G, Vatrella A, Busceti MT, Gallelli L, Preianò M, Lombardo N, Terracciano R, Maselli R

“…Girolamo Pelaia,1 Alessandro Vatrella,2 Maria Teresa Busceti,1 Luca Gallelli,3 Mariaimmacolata Preianò,3 Nicola Lombardo,1 Rosa Terracciano,3 Rosario Maselli1…”
Get full text

Update on optimal use of omalizumab in management of asthma by Pelaia, Girolamo, Gallelli, Luca, Renda, Teresa, Romeo, Pasquale, Busceti, Maria Teresa, Grembiale, Rosa Daniela, Maselli, Rosario, Marsico, Serafino Antonio, Vatrella, Alessandro

“…Omalizumab is a humanized monoclonal anti-IgE antibody recently approved for the treatment of severe allergic asthma. This drug inhibits allergic responses by…”
Get full text